Data / Drug companies / Chromo Laboratories India Private Limited
Chromo Laboratories India Private Limited: 46 products in the FDA NDC directory, labeler code 52562
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Chromo Laboratories India Private Limited (labeler code 52562) lists 46 products in the FDA National Drug Code Directory. By type: 46 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on September 1, 2025.
The request: Watch Chromo Laboratories India Private Limited (FDA labeler code 52562): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 52562
- Products in commercial distribution
- 46
- Packages
- 46
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule IV 6, Schedule V 1
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- September 21, 2011
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 46 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 46 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 46 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Armodafinil | 52562-039 | Powder | Bulk ingredients | September 1, 2025 |
| Modafinil | 52562-023 | Powder | Bulk ingredients | April 9, 2025 |
| Modafinil | 52562-023 | Powder | Bulk ingredients | April 9, 2025 |
| Abacavir sulfate | 52562-036 | Powder | Bulk ingredients | December 1, 2024 |
| Omeprazole magnesium | 52562-035 | Powder | Bulk ingredients | December 1, 2024 |
| Omeprazole | 52562-034 | Powder | Bulk ingredients | December 1, 2024 |
| Azilsartan kamedoxomil | 52562-033 | Powder | Bulk ingredients | December 1, 2024 |
| Sacubitril valsartan trisodium hemipentahydrate | 52562-032 | Powder | Bulk ingredients | December 1, 2024 |
| Sitagliptin phosphate monohydrate | 52562-037 | Powder | Bulk ingredients | September 14, 2024 |
| Pregabalin | 52562-028 | Powder | Bulk ingredients | February 1, 2023 |
| Sumatriptan succinate | 52562-024 | Powder | Bulk ingredients | December 1, 2022 |
| Oseltamivir phosphate | 52562-025 | Powder | Bulk ingredients | April 22, 2022 |
| Rosuvastatin calcium | 52562-030 | Powder | Bulk ingredients | March 3, 2022 |
| Lansoprazole | 52562-021 | Powder | Bulk ingredients | December 30, 2021 |
| Dolutegravir sodium ih | 52562-012 | Powder | Bulk ingredients | December 30, 2021 |
| Atazanavir sulfate | 52562-008 | Powder | Bulk ingredients | December 1, 2021 |
| Levocetirizine dihydrochloride-usp | 52562-006 | Powder | Bulk ingredients | December 1, 2021 |
| Eszopiclone | 52562-016 | Powder | Bulk ingredients | October 18, 2021 |
| Granisetron hydrochloride | 52562-015 | Powder | Bulk ingredients | October 18, 2021 |
| Levofloxacin hemihydrate | 52562-007 | Powder | Bulk ingredients | October 18, 2021 |
| Darunavir ethanolate | 52562-029 | Powder | Bulk ingredients | September 6, 2021 |
| Modafinil | 52562-023 | Powder | Bulk ingredients | September 6, 2021 |
| Zaleplon | 52562-017 | Powder | Bulk ingredients | June 19, 2021 |
| Naratriptan hydrochloride | 52562-014 | Powder | Bulk ingredients | June 19, 2021 |
| Ziprasidone mesilate trihydrate | 52562-031 | Powder | Bulk ingredients | May 29, 2021 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.